0001104659-24-002371.txt : 20240108
0001104659-24-002371.hdr.sgml : 20240108
20240108210633
ACCESSION NUMBER: 0001104659-24-002371
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240104
FILED AS OF DATE: 20240108
DATE AS OF CHANGE: 20240108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ashar Bhavesh
CENTRAL INDEX KEY: 0001849740
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39044
FILM NUMBER: 24521565
MAIL ADDRESS:
STREET 1: C/O SPRINGWORKS THERAPEUTICS
STREET 2: 100 WASHINGTON BLVD
CITY: STAMFORD
STATE: CT
ZIP: 05902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc.
CENTRAL INDEX KEY: 0001773427
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-883-9490
MAIL ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
4
1
tm242462-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-04
0
0001773427
SpringWorks Therapeutics, Inc.
SWTX
0001849740
Ashar Bhavesh
C/O SPRINGWORKS THERAPEUTICS, INC.
100 WASHINGTON BLVD.
STAMFORD
CT
06902
0
1
0
0
Chief Commercial Officer
0
Common Stock
2024-01-04
4
A
0
26445
0.00
A
70166
D
Common Stock
2024-01-05
4
F
0
2507
37.96
D
67659
D
Common Stock
2024-01-08
4
F
0
1449
41.53
D
66210
D
Stock Option (Right to Buy)
38.40
2024-01-04
4
A
0
75000
0
A
2034-01-03
Common Stock
75000
75000
D
This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty-three percent (33%) to vest on January 4, 2025, another thirty-three percent (33%) to vest on January 4, 2026 and the remaining thirty-four percent (34%) to vest on January 4, 2027, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.
Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs and does not represent a sale by the Reporting Person.
This option shall vest in forty-eight (48) equal monthly installments following January 4, 2024, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.
/s/ Francis I. Perier, Jr. as Attorney-in Fact
2024-01-08